Moderate mitral regurgitation and bypass: should the valve be repaired?

The dilemma of moderate ischemic mitral regurgitation

Ischemic mitral insufficiency (IMI) affects 12 to 30% of patients referred for coronary artery bypass grafting (CABG). While surgical correction is required for severe forms, moderate IMI remains a complex therapeutic "gray zone". This functional defect, resulting from left ventricular remodeling rather than organic damage to the leaflets, nevertheless doubles the risk of post-infarction mortality. The dilemma for the surgeon is crucial: is revascularization alone sufficient to restore valvular geometry, or should annuloplasty systematically be associated at the risk of prolonging cardiopulmonary bypass times?

This review systematises current data to define the optimal management strategy. The objective is to analyse the pathophysiology, diagnostic tools such as stress echocardiography and conflicting clinical evidence. The authors notably examine the discrepancies between the RIME study, favourable to the combined approach, and the results of the CTSN network which show no survival benefit at two years. The analysis aims to clarify the 2025 AHA/ACC and ESC/EACTS recommendations, which still classify this intervention as IIb due to a lack of established consensus.

A critical analysis at the heart of the therapeutic "grey zone"

This literature review synthesizes current data on the management of moderate ischemic mitral regurgitation (IMR) in patients undergoing coronary artery bypass grafting (CABG). The authors structured their analysis around a compilation of clinical and epidemiological evidence to clarify surgical options in this functional pathology.

The analyzed database includes:

• Epidemiological data: Analysis of registries showing an IMI prevalence of 40 to 50% in the acute phase of myocardial infarction, persisting in at least 12% of survivors at the chronic stage.
• Prognostic impact: Evaluation of the influence of even moderate IMR on mortality (risk multiplied by 1.5 to 2 according to the study by Grigioni et al.).
• Clinical trial comparison: Comparison of the RIME study results (demonstrating the superiority of the combined CABG + annuloplasty approach on ventricular remodeling) against the Cardiothoracic Surgical Trials Network (CTSN) study, which reports no difference in survival at 2 years.
• International guidelines: Analysis of AHA/ACC 2020 (class IIb) and ESC/EACTS 2025 recommendations.

The methodological approach is based on an evaluation of the pathophysiology (imbalance between closing and tethering forces) and the dynamic nature of the regurgitation, highlighting the importance of stress echocardiography when resting parameters are uncertain.

Results: The prognostic and clinical impact of moderate IMI

Moderate ischemic mitral insufficiency (IMI) is not a simple valvular pathology, but a geometric consequence of left ventricular remodeling. Epidemiological data compiled in this review highlight the scale of the problem: IMI is detected in 40 to 50% of patients in the acute phase of myocardial infarction. Among survivors, at least 12% maintain moderate to severe regurgitation. In patients who are candidates for isolated coronary artery bypass grafting (CABG), the prevalence of moderate IMI ranges between 12 and 30%.

The prognosis is heavily impacted. The presence of IMI, even moderate, increases the risk of death by 1.5 to 2 times. The authors report that this pathology is an independent predictor of post-infarction mortality, with the risk increasing proportionally to the degree of regurgitation.

The surgical management of this "grey area" is the subject of divergent results between the major clinical studies synthesized:

In the face of these discrepancies, international recommendations remain cautious. The AHA/ACC (2020) classifies the simultaneous correction of moderate IMR during CABG as category IIb (level of evidence B), meaning that the intervention may be considered without being mandatory. The European guidelines (ESC/EACTS 2025) do not provide a more definitive answer, leaving the decision to multidisciplinary consultation (Heart Team).

Sur le plan physiopathologique, l'étude décrit un déséquilibre entre les forces de traction (tethering) et les forces de fermeture. Le remodelage ventriculaire déplace les muscles papillaires, entraînant une déformation caractéristique de la valve antérieure, parfois appelée « signe de la mouette » (seagull sign).

Clinical analysis and data limitations

The synthesis of data highlights a major clinical paradox: although moderate IMI is an independent predictor of post-infarction mortality, its surgical treatment concomitant with CABG remains debated. This review emphasizes that the pathophysiological mechanism — an imbalance between traction forces (tethering) and closing forces — is eminently dynamic. The divergent results between the RIME study (favorable to annuloplasty for remodeling and BNP) and the CTSN study (neutral on 2-year survival) are explained by methodological heterogeneity and variable follow-up durations. One of the crucial limitations noted is the difficulty in reproducibility of the regurgitation degree assessment, as it fluctuates according to loading conditions and medical treatment.

Implications for practice

The main implication lies in moving beyond static assessment at rest. Since IMR may regress after revascularization or, conversely, progress depending on the irreversibility of left ventricular (LV) remodeling, stress echocardiography becomes a pivotal decision-making tool, as suggested by the 2025 ESC/EACTS guidelines. The practitioner must weigh the potential benefit of valvular correction against the deleterious prolongation of cardiopulmonary bypass and aortic cross-clamp times, particularly in multi-comorbid patients. In the absence of a strong consensus (Class IIb for AHA/ACC), the decision relies on a detailed phenotypic analysis of the LV rather than the grade of regurgitation alone.

Summary of results

This review highlights that moderate IMR affects up to 30% of patients scheduled for coronary artery bypass grafting (CABG), nearly doubling their long-term mortality risk. While the RIME study demonstrates an improvement in functional parameters and ventricular remodeling with combined annuloplasty, data from the CTSN network confirm no significant benefit in terms of survival or major cardiovascular events at 2 years compared to CABG alone.

In concrete terms, for the practitioner:

• Optimize diagnosis: In accordance with the 2025 ESC recommendations, systematically resort to stress echocardiography if resting IMR measurements are uncertain, in order to evaluate the dynamics of the regurgitation under load.
• Heart Team Decision: The addition of a valvular correction remains classified as IIb (AHA/ACC 2020); prioritize a multidisciplinary discussion to decide between the potential benefit of reverse remodeling and the risk associated with prolonged aortic clamping time.
• Targeted monitoring: Anticipate the risk of mitral regurgitation progression post-revascularization in patients presenting with irreversible left ventricular remodeling, a major factor in rehospitalization for cardiac decompensation.

Technical lexicon of the study

Ischemic mitral insufficiency (IMI): Secondary functional insufficiency caused not by structural damage to the valve leaflets, but by the remodeling and distortion of the subvalvular apparatus following myocardial injury.

Tethering: Pulling force exerted on the valve leaflets by the displaced subvalvular structures (chordae and papillary muscles), opposing the myocardial closing forces.

Seagull sign: Characteristic appearance of the anterior mitral valve leaflet showing abnormal angulation when the coaptation zone is displaced towards the ventricular cavity.

Reverse remodeling: Process of restoring ventricular geometry and function (positive remodeling), which can lead to a reduction in the severity of regurgitation after effective treatment.

Subvalvular apparatus: All structures including papillary muscles and chordae tendineae whose geometric distortion is the causal mechanism of ischemic mitral regurgitation.

Extracorporeal circulation: Cardiac and pulmonary support procedure whose prolonged duration during combined interventions (bypass and plasty) can increase perioperative risks.

Annular dilatation: Geometric remodeling process of the mitral annulus, often more pronounced in the septo-lateral axis, contributing to valvular leakage.

Information intended for healthcare professionals. This content may contain errors or truncated summaries. We recommend always verifying with the original source article. Delynov disclaims all responsibility regarding the use of this information. This document is not intended for patients or the general public.